Migraine drug fremanezumab tested for sleep benefits
NCT ID NCT04693533
First seen Jan 24, 2026 · Last updated Apr 25, 2026 · Updated 13 times
Summary
This study looked at whether fremanezumab, an FDA-approved migraine prevention drug, could also improve sleep quality in people with migraines. Researchers planned to track 22 adults aged 18-65 who have frequent migraines, measuring their sleep and migraine days before and during treatment. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BIDMC Headaceh Clinic
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.